Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease.

Tan Y, Ge G, Pan T, Wen D, Gan J.

PLoS One. 2014 Aug 20;9(8):e105192. doi: 10.1371/journal.pone.0105192.

2.

Serum microRNAs as potential biomarkers of primary biliary cirrhosis.

Tan Y, Pan T, Ye Y, Ge G, Chen L, Wen D, Zou S.

PLoS One. 2014 Oct 27;9(10):e111424. doi: 10.1371/journal.pone.0111424.

3.

Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.

Tan Y, Ge G, Pan T, Wen D, Gan J.

Clin Chim Acta. 2015 Dec 7;451(Pt B):232-9. doi: 10.1016/j.cca.2015.10.002.

PMID:
26483130
4.

A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.

Tan Y, Ge G, Pan T, Wen D, Chen L, Yu X, Zhou X, Gan J.

PLoS One. 2014 Sep 19;9(9):e107986. doi: 10.1371/journal.pone.0107986.

5.

Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.

Ouyang X, Jiang X, Gu D, Zhang Y, Kong SK, Jiang C, Xie W.

Int J Med Sci. 2016 Feb 18;13(3):195-205. doi: 10.7150/ijms.13996.

6.

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.

Pirola CJ, Fernández Gianotti T, Castaño GO, Mallardi P, San Martino J, Mora Gonzalez Lopez Ledesma M, Flichman D, Mirshahi F, Sanyal AJ, Sookoian S.

Gut. 2015 May;64(5):800-12. doi: 10.1136/gutjnl-2014-306996.

7.

Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.

Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA.

Tumour Biol. 2016 Sep;37(9):12273-12286.

PMID:
27271989
8.

Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.

Becker PP, Rau M, Schmitt J, Malsch C, Hammer C, Bantel H, Müllhaupt B, Geier A.

PLoS One. 2015 Nov 13;10(11):e0142661. doi: 10.1371/journal.pone.0142661.

9.

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.

Zheng G, Du L, Yang X, Zhang X, Wang L, Yang Y, Li J, Wang C.

Br J Cancer. 2014 Nov 11;111(10):1985-92. doi: 10.1038/bjc.2014.489.

10.

Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.

Zhang S, Ouyang X, Jiang X, Gu D, Lin Y, Kong SK, Xie W.

Int J Med Sci. 2015 Jul 16;12(7):590-8. doi: 10.7150/ijms.11525.

11.

Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.

Salvoza NC, Klinzing DC, Gopez-Cervantes J, Baclig MO.

PLoS One. 2016 Apr 14;11(4):e0153497. doi: 10.1371/journal.pone.0153497.

12.

A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.

Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.

Lancet Oncol. 2015 Jul;16(7):804-15. doi: 10.1016/S1470-2045(15)00048-0.

PMID:
26088272
13.

A circulating microrna profile is associated with late-stage neovascular age-related macular degeneration.

Grassmann F, Schoenberger PG, Brandl C, Schick T, Hasler D, Meister G, Fleckenstein M, Lindner M, Helbig H, Fauser S, Weber BH.

PLoS One. 2014 Sep 9;9(9):e107461. doi: 10.1371/journal.pone.0107461.

14.

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.

Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X, Wang Z, Qiu S, Wang X, Yang G, Sun H, Tang Z, Wu Y, Zhu H, Fan J.

J Clin Oncol. 2011 Dec 20;29(36):4781-8. doi: 10.1200/JCO.2011.38.2697.

PMID:
22105822
15.

Circulating microRNAs as biomarkers of adult Crohn's disease.

Jensen MD, Andersen RF, Christensen H, Nathan T, Kjeldsen J, Madsen JS.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1038-44. doi: 10.1097/MEG.0000000000000430.

PMID:
26230660
16.

Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.

Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, Run W, Tian L, Jia X, Gao Y.

Clin Sci (Lond). 2011 Mar;120(5):183-93. doi: 10.1042/CS20100297.

17.

Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.

Zhang X, Guo J, Fan S, Li Y, Wei L, Yang X, Jiang T, Chen Z, Wang C, Liu J, Ping Z, Xu D, Wang J, Li Z, Qiu Y, Li JC.

PLoS One. 2013 Dec 5;8(12):e81076. doi: 10.1371/journal.pone.0081076.

18.

Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis.

Wang W, Zhang Y, Zhu B, Duan T, Xu Q, Wang R, Lu L, Jiao Z.

Oncotarget. 2015 Dec 15;6(40):42557-68. doi: 10.18632/oncotarget.6449.

19.

miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.

Xu Q, Li Y, Shang YF, Wang HL, Yao MX.

World J Gastroenterol. 2015 Jan 14;21(2):511-6. doi: 10.3748/wjg.v21.i2.511.

20.

Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease.

Soronen J, Yki-Järvinen H, Zhou Y, Sädevirta S, Sarin AP, Leivonen M, Sevastianova K, Perttilä J, Laurila PP, Sigruener A, Schmitz G, Olkkonen VM.

Physiol Rep. 2016 Jan;4(1). pii: e12661. doi: 10.14814/phy2.12661.

Supplemental Content

Support Center